Trial reportSurgical endoscopy2025
Laparoscopic-guided transversus abdominis plane block combined with port-site infiltration for postoperative analgesia after gastric bypass: a randomized, double-blind, controlled trial.
Trial report in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Efficacy of Transversus Abdominis Plane Blocks in Roux-en-Y Gastric Bypass - a Systematic Review and Meta-Analysis of Randomised Control Trials.Obesity surgery · 2026Pooled it
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients undergoing laparoscopic gastric bypass (LGBP) commonly experience moderate to severe postoperative pain. We conducted a randomized, prospective double-blind placebo-controlled study to evaluate the analgesic effect of laparoscopic-guided TAP (LG-TAP) block after LGBP in a high-volume bariatric center, applying an enhanced recovery after metabolic and bariatric surgery protocol. MATERIALS AND
methods84 patients were randomly allocated to receive LG-TAP block with local anesthetic (LA) or saline solution (placebo), both combined with port-site infiltration with LA (LA-PSI). Primary outcome was pain score measured in post-anesthesia care unit (PACU), and at 6, 12, and 24 h after surgery. Secondary outcomes included postoperative nausea and/or vomiting, analgesic requirement, time to walking, time to flatus, length of hospital stay, and surgical complications.
resultsDifferences were observed in intra-group comparisons (LG-TAP vs. placebo) for the primary outcome-NRS in postoperative analgesia-with a median (IQR) NRS of 4 (2-5) vs. 2 (2-5) in PACU, 4.5 (2-6) vs. 2.5 (1-6) at 6 h and 3 (0-5) vs. 2 (0-4) at 12 h, although no statistically differences were demonstrated (PACU: p-value = 0.26; 6 h: p-value = 0.3; 12 h: p-value = 0.24). No statistically and clinically differences were observed for NRS at 24 h postoperatively with a median (IQR) of 1 (0-3) vs. 1 (0-4) at 24 h; p = 0.89. No differences were observed as regards secondary outcomes.
conclusionWhile a potential analgesic effect of saline solution through fascial hydrodissection cannot be excluded, our results more convincingly support that LG-TAP block provides no significant analgesic effect when LA-PSI is adequately implemented.
Indexed as
Identifiers
40588600What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.